Allarity Therapeutics Europe ApS
-
-
Active
- Registration 34623562
- APS
- Established 1 August, 2012
Relations
Past relations
- Legal owners
-
-
Allarity Acquisition Subsidiary, Inc.
2021-12-21 – 100% ownership (2021-12-21 – ) 100% voting rights (2021-12-21 – ) -
Allarity Therapeutics A/S 20% ownership (2013-09-20 – 2015-06-04 ) 100% ownership (2018-05-30 – 2021-12-21 ) 20% voting rights (2013-09-20 – 2015-06-04 ) 100% voting rights (2018-05-30 – 2021-12-21 )
-
Oncology Venture Sweden AB
2015-06-04 – 2018-05-30 100% ownership (2015-06-04 – 2018-05-30 ) 100% voting rights (2015-06-04 – 2018-05-30 ) -
SASS & LARSEN ApS 15% ownership (2015-03-06 – 2015-06-04 ) 15% voting rights (2015-03-06 – 2015-06-04 )
-
Allarity Therapeutics A/S 20% ownership (2013-09-20 – 2015-06-04 ) 100% ownership (2018-05-30 – 2021-12-21 ) 20% voting rights (2013-09-20 – 2015-06-04 ) 100% voting rights (2018-05-30 – 2021-12-21 )
-
BUHL KRONE HOLDING ApS 20% ownership (2013-09-20 – 2015-06-04 ) 20% voting rights (2013-09-20 – 2015-06-04 )
-
TIMPCO NB ApS 5% ownership (2013-11-26 – 2015-06-04 ) 5% voting rights (2013-11-26 – 2015-06-04 )
-
Styrelsen for Forskning og Uddannelse 15% ownership (2015-02-06 – 2015-06-04 ) 15% voting rights (2015-02-06 – 2015-06-04 )
-
- Directors
-
-
Steen Meier Knudsen
2023-12-12 – -
Jeffrey Stuart Ervin
2025-07-04 – -
Alexander Epshinsky
2024-09-12 – 2025-07-04 -
Joan Yvonne Brown
2022-06-29 – 2024-09-12 -
James G. Cullem
2022-06-29 – 2023-12-12 -
Steen Meier Knudsen
2022-08-01 – 2023-12-11 -
Stefano Roberto Carchedi
2021-12-23 – 2022-06-29 -
James G. Cullem
2022-02-01 – 2022-06-28 -
Jens Erik Knudsen
2021-12-23 – 2022-06-27 -
Thomas Henrik Jensen
2020-10-20 – 2021-12-23 -
Henrik Kristian Moltke
2019-09-30 – 2020-10-20 -
Peter Buhl
2012-08-01 – 2019-09-30
-
- Board members
-
-
Steen Meier Knudsen
2015-05-05 – 2018-12-11 -
Ulla Hald Buhl
2015-02-06 – 2018-12-11 -
Peter Birk Rasmussen
2015-02-06 – 2018-12-11 -
Duncan Charles McNaught Moore
2015-02-06 – 2018-12-11 -
Carani Balarman Sanjeevi
2015-02-06 – 2018-12-11 -
Jørgen Søberg Petersen
2015-02-06 – 2015-05-05
-
- Subsidiaries
-
-
Allarity Therapeutics Denmark ApS 33.33% ownership (2017-02-13 – 2021-12-21 ) 33.33% voting rights (2017-02-13 – 2021-12-21 )
-
Employees
Allarity Therapeutics Europe ApS has 4.00 full time equivalents (FTEs) and 4.00 employees as of 1 May, 2025.
Financial reports
Revenue
Profit/loss
| '000 | 12-2013 | 12-2014 | 12-2015 | 12-2016 | 12-2017 | |
|---|---|---|---|---|---|---|
| Currency | DKK | DKK | DKK | DKK | DKK | |
| Revenue | 0 | 61 | 0 | 0 | 0 | |
| Raw materials and consumables used | 0 | 0 | 0 | 0 | 0 | |
| Other external expenses | 482 | 343 | 0 | 0 | 0 | |
| Gross profit loss | 0 | 0 | -6,346 | -26,151 | -32,986 | |
| Employee benefits expense | 0 | 0 | 153 | 2,066 | 2,053 | |
| Wages and salaries | 0 | 0 | 0 | 0 | 0 | |
| Depreciation amortisation expense and impairment losses of prop | 0 | 0 | 0 | 0 | 0 | |
| Profit loss from ordinary operating activities | -623 | -422 | -6,726 | -28,596 | -38,450 | |
| Profit loss from ordinary activities before tax | -623 | -422 | -7,322 | -28,571 | -49,103 | |
| Other finance expenses | 0 | 0 | 596 | 692 | 13,393 | |
| Tax expense | 0 | 0 | 0 | 0 | 0 | |
| Profit loss | -623 | -422 | -7,322 | -23,071 | -43,604 |